Home  >  Products  >  GPIHBP1 (glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 ) Blocking Peptide (the C terminal of GPIHBP1)(100ug)
GPIHBP1 (glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 ) Blocking Peptide (the C terminal of GPIHBP1)(100ug)

GPIHBP1 (glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 ) Blocking Peptide (the C terminal of GPIHBP1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GPIHBP1 Antibody (ARP64479_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64479
Size: 100ug
Weight: 18kDa
Gene: 338328
Format: Lyophilized powder
Target: Dietary fats are packaged by intestine into triglyceride-rich lipoproteins called chylomicrons. The triglycerides in chylomicrons are hydrolyzed by lipoprotein lipase (LPL: MIM 609708) along the luminal surface of capillaries, mainly in heart, skeletal muscle, and adipose tissue. GPIHBP1 is a capillary endothelial cell protein that provides a platform for LPL-mediated processing of chylomicrons.
Alternative names: GPI-HBP1
See Full Product Listings >